IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV12I9A89

Acquired coronary artery aneurysm following treatment with bioresorbable vascular scaffolds

Kevin O’Gallagher*, BA (Hons), MBBS, MRCP; Roberto Nerla, PhD; Jonathan Hill, MA, MBChb, FRCP; Jonathan Byrne, MBChB, PhD, FRCP

A 41-year-old female underwent deployment of two bioresorbable vascular scaffolds (BVS) (3.5×28 mm, 3.5×18 mm) (Abbott Vascular, Santa Clara, CA, USA) to a long segment of disease in the right coronary artery (RCA) as a staged intervention to bystander disease following a myocardial infarction. Due to a significant waist post deployment, post-dilation with 3.5×20 mm Pantera (Biotronik, Berlin, Germany) and 3.5×12 mm Quantum Apex™ (Boston Scientific, Marlborough, MA, USA) non-compliant balloons to 18 atm was required.

She re-presented with angina 21 months later. Angiography revealed a significant ostial RCA stenosis, with a localised coronary artery aneurysm within the scaffolded segment (Panel A). Pressure wire assessment yielded an FFR of 0.76 with a step at the ostium. Optical coherence tomography confirmed a large, acquired aneurysm at the point of minimal scaffold overlap (Panel B, Panel C). No malapposition was observed, and the scaffold appeared to have expanded with the vessel far beyond normal scaffold dimensions. A short drug-eluting stent (DES) was deployed to the ostium. The aneurysmal segment was managed conservatively with dual antiplatelet therapy (aspirin and clopidogrel).

This extreme form of positive remodelling in a BVS has not, to our knowledge, been described previously. The mechanism of acquired aneurysm following DES/BVS deployment remains unclear; however, hypersensitivity to the drug and/or polymer is possible. In this case, it is possible that “double-dose” everolimus at the point of BVS overlap may have been a factor in aneurysm formation.

Conflict of interest statement

J. Hill has received consulting fees from Abbott and St. Jude Medical. The other authors have no conflicts of interest to declare.

Volume 12 Number 9
Oct 20, 2016
Volume 12 Number 9
View full issue


Key metrics

Suggested by Cory

IMAGE IN CARDIOLOGY

10.4244/EIJV12I1A10 May 16, 2016
Coronary aneurysm without malapposition after bioresorbable vascular scaffold implantation
Timmers L et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJ-D-16-00323 Jan 20, 2017
Delayed fracture of a bioresorbable vascular scaffold implanted for in-stent restenosis
Bastante T et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I7A142 Sep 18, 2016
Plaque protrusion compromising bioresorbable coronary scaffold patency
Floré V et al
free
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
38.95

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved